Chemicals · Founded 2009 · www.vscl.net.in · NSE · ISIN INE551Q01028
No Notes Added Yet
Business
Vadivarhe Speciality Chemicals Ltd. (VSCL) is engaged in the manufacturing and supply of speciality chemicals. Its core business model revolves around developing, producing, and distributing chemicals that provide specific performance attributes or functionalities for various industrial applications. The company operates primarily in a Business-to-Business (B2B) model, selling its products as critical intermediates or additives to customers in diverse end-user industries. VSCL generates revenue through the sale of these manufactured speciality chemical products.
Revenue Mix
Without specific company data, the exact breakdown of major business segments or revenue contribution is not available. However, typical speciality chemical companies often segment their business by end-use application (e.g., agrochemicals, pharmaceuticals, personal care, textiles, construction, industrial additives) or by chemical type (e.g., intermediates, performance chemicals, polymers). It is likely that VSCL's revenue is derived from a portfolio of products catering to one or more of these specialized areas.
Industry
The Indian chemicals industry is diverse, with the speciality chemicals segment being highly dynamic, innovation-driven, and fragmented, featuring a mix of large diversified players, mid-sized niche specialists, and smaller regional manufacturers. It is characterized by product differentiation, technical service, and often long-term customer relationships. VSCL, as a speciality chemicals player, likely positions itself by focusing on specific product chemistries, offering customized solutions, maintaining product quality, and potentially achieving cost-effectiveness in its chosen niches. Its positioning would be relative to both larger domestic and international competitors, as well as smaller domestic peers in specific product lines.
MOAT
For a speciality chemicals company like VSCL, potential competitive advantages often include:
Switching Costs: If its products are critical inputs integrated into customer formulations or processes, switching suppliers can be complex, costly, and time-consuming due to re-testing, regulatory approvals, and potential production disruptions.
Proprietary Formulations/Technical Expertise: Development of unique or difficult-to-replicate chemical formulations, processes, or application know-how.
Customer Relationships & Service: Deep technical collaboration with customers, offering tailored solutions and strong after-sales support, leading to embedded relationships.
Regulatory Compliance Expertise: Ability to meet stringent quality and regulatory standards required by specific end-user industries (e.g., pharmaceuticals, food additives).
Without specific details, the extent and durability of these advantages for VSCL cannot be definitively assessed.
Growth Drivers
Key factors that could drive growth for VSCL over the next 3-5 years include:
Growth in End-User Industries: Increased demand from client sectors such as pharmaceuticals, agrochemicals, automotive, construction, or personal care products, which are consumers of speciality chemicals.
Import Substitution: Government initiatives and industry trends favoring domestic manufacturing ("Make in India") could lead to increased demand for locally produced speciality chemicals.
New Product Development: Successful R&D leading to the introduction of new, high-value-added products or applications addressing evolving industry needs.
Capacity Expansion: Investment in expanding manufacturing capacities to meet growing demand or capture new market share.
Export Opportunities: Leveraging competitive manufacturing costs and product quality to cater to international markets, especially in regions with high demand for specific chemicals.
Risks
Raw Material Price Volatility: Fluctuations in the cost of key feedstocks, often derived from crude oil or other basic chemicals, can impact profit margins.
Intense Competition: The speciality chemicals sector is competitive, facing pressure from larger global players and agile domestic competitors, potentially leading to pricing pressures.
Environmental & Regulatory Risks: Strict environmental protection regulations can lead to higher compliance costs, operational restrictions, or potential penalties.
Technological Obsolescence: Continuous innovation is required; failure to keep pace with new technologies or product developments could erode market share.
Demand Cyclicality: Performance can be linked to the economic cycles and health of the end-user industries it serves.
Foreign Exchange Fluctuations: For companies involved in significant imports of raw materials or exports of finished goods, currency volatility can impact profitability.
Management & Ownership
As is common with many Indian companies, VSCL is likely promoter-driven, meaning the founding family or individuals hold a significant stake and play a key role in management. While specific details about the promoters' background or the management team's experience are not available, their strategic vision, operational efficiency, and commitment to R&D and customer relationships would be crucial for the company's long-term success. The ownership structure typically involves promoter holdings, institutional investors, and public shareholders.
Outlook
VSCL operates within the dynamic Indian speciality chemicals sector, which generally benefits from underlying industrial growth and government impetus for domestic manufacturing. The bull case for VSCL rests on its ability to leverage its technical expertise, develop a robust product pipeline, deepen customer relationships, and expand capacity effectively to capitalize on demand from its end-user industries. Growth in these sectors, coupled with potential import substitution opportunities, could drive revenue and profitability.
Conversely, the bear case highlights significant industry challenges. VSCL faces risks from volatile raw material costs, intense competition, and stringent regulatory environments. The company's ability to maintain a competitive edge through innovation and cost management will be crucial. A failure to adapt to changing market demands, manage operational risks, or effectively pass on cost increases to customers could negatively impact its financial performance. The outlook remains balanced, contingent on the company's execution capabilities in a challenging yet growing industry landscape.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Jun 2019 | Dec 2019 | Jun 2020 | Dec 2020 | Jun 2021 | Dec 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 6 | 8 | 6 | 12 | 11 | 5 | 7 | 4 | 4 | 6 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 6 | 8 | 6 | 12 | 11 | 5 | 7 | 4 | 4 | 6 |
| Total Expenditure | 5 | 6 | 6 | 11 | 10 | 8 | 7 | 5 | 5 | 8 |
| Operating Profit | 1 | 1 | 1 | 1 | 1 | -3 | 0 | -0 | -1 | -2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 0 | 0 | 0 | -4 | -1 | -1 | -2 | -3 |
| Provision for Tax | 0 | 0 | -0 | 0 | -0 | 1 | 0 | 0 | 0 | 0 |
| Profit After Tax | 0 | 1 | 0 | 0 | 0 | -5 | -1 | -1 | -2 | -3 |
| Adjustments | -0 | -1 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | 0 | 0 | 0 | 0 | 0 | -5 | -1 | -1 | -2 | -3 |
| Adjusted Earnings Per Share | 0 | 0.5 | 0.1 | 0.2 | 0.1 | -3.8 | -0.6 | -0.7 | -1.5 | -2.3 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 19 | 26 | 35 | 26 | 32 | 30 | 26 | 21 | 44 | 40 | 38 | 21 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
| Total Income | 19 | 26 | 35 | 26 | 33 | 30 | 27 | 22 | 45 | 41 | 38 | 21 |
| Total Expenditure | 12 | 19 | 25 | 22 | 30 | 39 | 27 | 28 | 41 | 36 | 44 | 25 |
| Operating Profit | 8 | 8 | 11 | 4 | 3 | -9 | -0 | -6 | 4 | 5 | -6 | -3 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 6 | 5 | 9 | 2 | 0 | -12 | -3 | -10 | 1 | 2 | -9 | -7 |
| Provision for Tax | 2 | 2 | 3 | 0 | -0 | -2 | 0 | 0 | 0 | 1 | 0 | 0 |
| Profit After Tax | 4 | 3 | 6 | 2 | 0 | -10 | -3 | -10 | 1 | 0 | -9 | -7 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 4 | 3 | 6 | 2 | 0 | -10 | -3 | -10 | 1 | 0 | -9 | -7 |
| Adjusted Earnings Per Share | 0 | 0 | 0 | 1.4 | 0 | -7.7 | -2.2 | -7.5 | 0.9 | 0 | -7.2 | -5.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -5% | 22% | 5% | 7% |
| Operating Profit CAGR | -220% | 0% | 0% | NAN% |
| PAT CAGR | 0% | 0% | 0% | NAN% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -27% | -21% | -8% | NA% |
| ROE Average | -499% | -160% | -118% | -50% |
| ROCE Average | -23% | -1% | -6% | 3% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 15 | 18 | 23 | 27 | 27 | 18 | 15 | 5 | 6 | 6 | -3 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 8 | 5 | 4 | 4 | 13 | 10 | 15 | 16 | 16 | 19 | 23 |
| Other Non-Current Liabilities | -1 | 1 | 3 | 3 | 3 | 1 | 1 | 1 | 0 | 0 | 0 |
| Total Current Liabilities | 6 | 9 | 15 | 9 | 15 | 23 | 17 | 20 | 23 | 16 | 22 |
| Total Liabilities | 28 | 34 | 46 | 44 | 58 | 51 | 47 | 42 | 46 | 42 | 43 |
| Fixed Assets | 15 | 15 | 17 | 20 | 26 | 25 | 26 | 24 | 23 | 22 | 22 |
| Other Non-Current Assets | 6 | 7 | 7 | 8 | 8 | 5 | 2 | 3 | 3 | 2 | 0 |
| Total Current Assets | 8 | 13 | 22 | 16 | 23 | 21 | 19 | 14 | 20 | 18 | 20 |
| Total Assets | 28 | 34 | 46 | 44 | 58 | 51 | 47 | 42 | 46 | 42 | 43 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Cash Flow from Operating Activities | 5 | 4 | 2 | 7 | -1 | 4 | -0 | 1 | -0 | 2 | -7 |
| Cash Flow from Investing Activities | -0 | -1 | -4 | -5 | -8 | -2 | 0 | -1 | -1 | -1 | -1 |
| Cash Flow from Financing Activities | -4 | -4 | 2 | -1 | 9 | -2 | 1 | -1 | 1 | -2 | 9 |
| Net Cash Inflow / Outflow | 1 | -1 | -0 | 1 | -0 | 0 | 0 | -0 | 0 | -0 | 0 |
| Closing Cash & Cash Equivalent | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0 | 0 | 0 | 1.38 | 0.05 | -7.7 | -2.16 | -7.52 | 0.9 | 0.05 | -7.25 |
| CEPS(Rs) | 4.19 | 3.65 | 5.91 | 2.38 | 1.32 | -6.33 | -0.75 | -6.12 | 2.3 | 1.41 | -5.8 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 0 | 0 | 0 | 21.46 | 21.5 | 13.81 | 11.65 | 4.13 | 5.03 | 5.08 | -2.17 |
| Core EBITDA Margin(%) | 38.36 | 26.47 | 28.33 | 14.56 | 7.18 | -30.66 | -2.33 | -32.29 | 7.02 | 11.03 | -16.11 |
| EBIT Margin(%) | 33.33 | 23.28 | 28.08 | 11.37 | 3.6 | -35.21 | -4.82 | -36.9 | 6.3 | 8.32 | -19.9 |
| Pre Tax Margin(%) | 28.79 | 18.95 | 25.76 | 8.39 | 0.16 | -39.76 | -9.79 | -44.79 | 2.63 | 3.76 | -24.44 |
| PAT Margin (%) | 20.29 | 12.1 | 16.37 | 6.82 | 0.19 | -32.64 | -10.43 | -44.79 | 2.63 | 0.15 | -24.44 |
| Cash Profit Margin (%) | 25.86 | 15.8 | 19.47 | 11.74 | 5.22 | -26.84 | -3.6 | -36.45 | 6.72 | 4.48 | -19.57 |
| ROA(%) | 13.61 | 10.81 | 15.07 | 3.93 | 0.12 | -18.04 | -5.6 | -21.62 | 2.6 | 0.14 | -21.97 |
| ROE(%) | 31.7 | 20.84 | 29.06 | 6.94 | 0.23 | -43.6 | -16.97 | -95.27 | 19.6 | 0.95 | -499.06 |
| ROCE(%) | 24.36 | 23.24 | 31.84 | 8.03 | 2.72 | -24.74 | -3.37 | -23.27 | 8.73 | 10.1 | -22.89 |
| Receivable days | 82.24 | 79.53 | 118.25 | 168.78 | 120.2 | 126.36 | 119.14 | 94.74 | 32.57 | 48.78 | 63.57 |
| Inventory Days | 26.56 | 23.92 | 21.9 | 35.76 | 54.62 | 81.32 | 70.16 | 86.49 | 64.34 | 78.12 | 88.1 |
| Payable days | 108.05 | 60.71 | 92.79 | 162.94 | 128.06 | 150.19 | 212.87 | 190.97 | 135.23 | 150.19 | 96.51 |
| PER(x) | 0 | 0 | 0 | 61.27 | 762.89 | 0 | 0 | 0 | 30.7 | 644.49 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 3.95 | 1.72 | 0.47 | 1.08 | 6.05 | 5.48 | 6.11 | -12.09 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.86 | 0.57 | 0.71 | 4.58 | 2.09 | 0.9 | 1.46 | 2.59 | 1.4 | 1.63 | 1.82 |
| EV/Core EBITDA(x) | 2.14 | 1.99 | 2.3 | 28.19 | 24.25 | -3.03 | -173.89 | -8.71 | 14.71 | 12.88 | -11.99 |
| Net Sales Growth(%) | 37.15 | 38.13 | 33.28 | -27.03 | 26.6 | -6.85 | -12.18 | -18.97 | 103.64 | -8.25 | -5.42 |
| EBIT Growth(%) | 467.42 | -0.48 | 58.57 | -71.47 | -60.42 | -1011.56 | 87.99 | -520.87 | 134.79 | 21.08 | -326.27 |
| PAT Growth(%) | 5347.26 | -15.04 | 77.91 | -70.62 | -96.49 | 0 | 71.94 | -248.05 | 111.94 | -94.64 | 0 |
| EPS Growth(%) | 0 | 0 | 0 | 0 | -96.49 | 0 | 71.94 | -248.05 | 111.94 | -94.64 | 0 |
| Debt/Equity(x) | 0.89 | 0.59 | 0.54 | 0.35 | 0.76 | 1.11 | 1.57 | 4.62 | 4.19 | 4.03 | -12.98 |
| Current Ratio(x) | 1.28 | 1.37 | 1.4 | 1.72 | 1.58 | 0.92 | 1.11 | 0.72 | 0.87 | 1.14 | 0.9 |
| Quick Ratio(x) | 1.08 | 1.11 | 1.27 | 1.39 | 1.13 | 0.62 | 0.91 | 0.38 | 0.5 | 0.6 | 0.46 |
| Interest Cover(x) | 7.34 | 5.38 | 12.1 | 3.81 | 1.05 | -7.74 | -0.97 | -4.68 | 1.71 | 1.82 | -4.38 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0.09 | 0.44 | 2.39 | 1.46 | 0.76 | 0.76 | 0.66 | 1.07 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.64 | 74.64 | 69.95 | 66.83 | 66.83 | 66.83 | 66.83 | 66.83 | 66.83 | 71.73 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 25.36 | 25.36 | 30.05 | 33.17 | 33.17 | 33.17 | 33.17 | 33.17 | 33.17 | 28.27 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.95 | 0.95 | 0.89 | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 | 1.08 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.32 | 0.32 | 0.38 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -5% | +22% | +5% | +7% |
| Operating Profit CAGR | -220% | — | — | 0% |
| PAT CAGR | — | — | — | 0% |
| Share Price CAGR | -27% | -21% | -8% | — |
| ROE Average | -499% | -160% | -118% | -50% |
| ROCE Average | -23% | -1% | -6% | +3% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.64 | 74.64 | 69.95 | 66.83 | 66.83 | 66.83 | 66.83 | 66.83 | 66.83 | 71.73 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 25.36 | 25.36 | 30.05 | 33.17 | 33.17 | 33.17 | 33.17 | 33.17 | 33.17 | 28.27 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.95 | 0.95 | 0.89 | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 | 1.08 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.32 | 0.32 | 0.38 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.5 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.